OTC Pharmaceuticals - Egypt

  • Egypt
  • In 2024, the revenue in the OTC Pharmaceuticals market in Egypt amounts to US$1,500.00m.
  • It is projected to experience an annual growth rate of 11.27% (CAGR 2024-2029).
  • Among the various markets, the largest one is Vitamins & Minerals, which recorded a market volume of US$533.30m in 2024.
  • In comparison to other countries, the in the United States generates the highest revenue in the OTC Pharmaceuticals market, reaching US$41,240.00m in 2024.
  • Considering the population figures, the per person revenue generated in Egypt in 2024 is US$13.10.
  • Furthermore, it is estimated that by 2024, 8.48% of the total revenue in the OTC Pharmaceuticals market will come from online sales.
  • Despite a growing demand for OTC pharmaceuticals in Egypt, the market is hindered by limited access to affordable healthcare.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Egypt is experiencing significant growth and development due to various factors.

Customer preferences:
Egyptian consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several reasons. Firstly, OTC medications are easily accessible and do not require a prescription, which makes them convenient for consumers seeking immediate relief from common ailments. Secondly, OTC products are often more affordable compared to prescription medications, making them a cost-effective option for many Egyptians. Lastly, the increased awareness and education about self-care and self-medication have also contributed to the rise in demand for OTC pharmaceuticals in Egypt.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Egypt is the increasing demand for vitamins and dietary supplements. As consumers become more health-conscious, there is a growing interest in preventive healthcare and maintaining overall well-being. This has led to a surge in the consumption of vitamins, minerals, and dietary supplements, which are readily available over-the-counter. Additionally, there is a rising trend of self-medication for minor ailments such as headaches, cold and flu symptoms, and digestive issues. This has resulted in an increased demand for OTC pain relievers, cough and cold medications, and antacids.

Local special circumstances:
The Egyptian market has its own unique characteristics that contribute to the development of the OTC Pharmaceuticals market. One such factor is the high prevalence of chronic diseases such as diabetes and cardiovascular diseases in the country. As a result, there is a continuous demand for OTC medications to manage these conditions. Additionally, the large population of Egypt, combined with the increasing urbanization and changing lifestyle patterns, has created a favorable environment for the growth of the OTC Pharmaceuticals market.

Underlying macroeconomic factors:
Several macroeconomic factors have played a role in the development of the OTC Pharmaceuticals market in Egypt. The country has witnessed a steady economic growth in recent years, which has resulted in an increase in disposable income among the population. This has allowed consumers to spend more on healthcare products, including OTC pharmaceuticals. Furthermore, the government's efforts to improve healthcare infrastructure and expand access to healthcare services have also contributed to the growth of the OTC Pharmaceuticals market. These initiatives have increased awareness about self-care and encouraged consumers to take responsibility for their own health.In conclusion, the OTC Pharmaceuticals market in Egypt is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for OTC medications, particularly vitamins and dietary supplements, reflects the growing health-consciousness among Egyptian consumers. The prevalence of chronic diseases and the large population of Egypt also contribute to the development of the market. Additionally, the country's economic growth and government initiatives have created a favorable environment for the growth of the OTC Pharmaceuticals market in Egypt.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)